Home/Filings/4/0000950170-24-128206
4//SEC Filing

Hopkins Janet Jill 4

Accession 0000950170-24-128206

CIK 0001501796other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 9:06 PM ET

Size

21.5 KB

Accession

0000950170-24-128206

Insider Transaction Report

Form 4
Period: 2024-11-18
Hopkins Janet Jill
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-11-18$9.36/sh11,822$110,663151,693 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.36 to $9.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Aura Biosciences, Inc.

CIK 0001501796

Entity typeother

Related Parties

1
  • filerCIK 0001997710

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 9:06 PM ET
Size
21.5 KB